Koers Tibet Pharmaceuticals, Inc. Other OTC
Aandelen
TBET
VGG886151023
Farmaceutische producten
Omzet 2009 | 23,01 mln. 21,28 mln. | Omzet 2010 | 32,36 mln. 29,93 mln. | Marktkapitalisatie | 14 12,95 |
---|---|---|---|---|---|
Nettowinst (verlies) 2009 | 9 mln. 8,32 mln. | Nettowinst (verlies) 2010 | 13 mln. 12,02 mln. | EV/omzet 2009 * | - |
Nettoliquiditeiten 2009 * | - 0 | Nettoliquiditeiten 2010 * | - 0 | EV/omzet 2010 * | - |
K/w-verhouding 2009 * |
-
| K/w-verhouding 2010 * |
-
| Werknemers | - |
Dividendrendement 2009 * |
-
| Dividendrendement 2010 * |
-
| Vrij verhandelbaar | 100% |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+22,67% | 5,41 mld. | |
-35,93% | 3,52 mld. | |
-6,69% | 2,96 mld. | |
-27,73% | 2,6 mld. | |
-11,46% | 2,29 mld. | |
+38,57% | 1,89 mld. | |
+38,46% | 1,47 mld. | |
-16,41% | 1,43 mld. | |
+42,86% | 1,36 mld. |